Recommendations for Fully Vaccinated People
COVID-19 Homepage

COVID-NET Overview and Methods
About COVID-NET
The Coronavirus Disease 2019 (COVID-19) Hospitalization Surveillance Network (COVID-NET) is part of the Respiratory Virus Hospitalization Surveillance Network (RESP-NET) which is designed to conduct population-based surveillance for laboratory-confirmed COVID-19, RSV, and influenza-associated hospitalizations. RESP-NET also includes surveillance networks for respiratory syncytial virus (RSV) and influenza (also known as RSV-NET and FluSurv-NET, respectively).
COVID-NET collects surveillance data on laboratory-confirmed, COVID-19-associated hospitalizations among children and adults. Data are collected and reported from a network of sites in acute-care hospitals across 98 counties in 13 states.
See the rates of COVID-19-associated hospitalizations each year
Why COVID-NET Data Are Important
COVID-NET is a population-based surveillance system. Population-based surveillance is the active collection, analysis, and interpretation of data on a population in a specified geographic area.
Tracking COVID-19-associated hospitalization rates helps public health professionals understand trends in virus circulation, estimate disease burden, and respond to outbreaks. Hospitalization rates are updated weekly on the COVID-NET Interactive Data Dashboard. Collecting demographic and more detailed clinical information, including underlying conditions, allows CDC to better understand COVID-19-associated hospitalization trends and determine who is most at risk.
Hospitalization rates show how many people in the surveillance area are hospitalized with COVID-19, compared to the total number of people residing in that area.
Case Definition
A case is defined by laboratory confirmed SARS-CoV-2 in a person who:
- Lives in a defined COVID-NET surveillance area AND
- Tests positive for SARS-CoV-2 within 14 days before or during hospitalization.
Evidence of COVID-19 infection can be obtained through several laboratory tests:
- Molecular assays, such as reverse transcription polymerase chain reaction (RT-PCR)
- Commercially available rapid antigen detection tests
- Serology (antibody) tests (must be paired acute and convalescent specimens)
Calculating Hospitalization Rates
To calculate COVID-19-associated hospitalization rates, COVID-NET collects the following data from identified cases:
- Age
- Sex
- Race and ethnicity
- County of residence
- Date of hospital admission
- Date of SARS-CoV-2 test
- Positive SARS-CoV-2 test result
Hospitalization rates are calculated as the number of residents in a surveillance area who are hospitalized with laboratory-confirmed COVID-19, divided by the total population estimate for that area. NCHS bridged-race population estimates are used as denominators for rate calculations.
How COVID-NET Hospitalization Data Are Different from Hospitalizations Reported in National and State Case Counts
COVID-NET data differ from hospitalizations reported in national and state case counts in multiple ways. First, state and national COVID-19 case reporting is based on all people who test positive using a healthcare provider-administered test for COVID-19 in the United States. COVID-NET is limited to COVID-19-associated hospitalizations captured in the COVID-NET surveillance area. Second, COVID-NET reports rates, not just counts. These rates show how many people are hospitalized with COVID-19 in the surveillance area, compared to the population residing in that area.
Collecting Clinical Data
COVID-NET surveillance began tracking COVID-19-associated hospitalizations in adults in March of 2020.
Cases are identified by reviewing state surveillance system databases, health information exchanges, hospital admission and laboratory databases, and infection control logs for patients hospitalized with a positive SARS-CoV-2 test result. Data collected are used to estimate age-specific hospitalization rates on a weekly and monthly basis and describe demographic and clinical characteristics of patients hospitalized with COVID-19.
Trained surveillance officers collect clinical data using a standardized case reporting form. Clinical data collected include:
- Medical history (e.g., underlying health conditions)
- Clinical course (i.e., progression of the COVID-19 illness such as admission to an ICU)
- Medical interventions (i.e., medical care for the COVID-19 illness such as need for mechanical ventilation)
- Outcomes (i.e., discharged from the hospital, or death)
- COVID-19 vaccination history
COVID-NET Surveillance Area
COVID-NET currently comprises 98 counties in the 13 states participating in the Emerging Infections Program (EIP) and the Influenza Hospitalization Surveillance Project (IHSP). The participating states are California, Colorado, Connecticut, Georgia, Maryland, Michigan, Minnesota, New Mexico, New York, Ohio, Oregon, Tennessee, and Utah.
COVID-NET covers approximately 10 percent of the U.S. population. The counties covered are located in 9 of the 10 Health and Human Services (HHS) regions. The designated COVID-NET surveillance area is generally similar to the U.S. population by demographics; however, the statistics generated using COVID-NET data might not be generalizable to the entire country.
The map and table, above, describe the current sites participating in COVID-NET. The table below summaries changes in participating sites by surveillance season. Data used to calculate hospitalization rates are generated by all counties included in surveillance. Clinical data on medical history, clinical course, medical interventions, outcomes, and vaccination history are reported using data from a subset of these counties.
Year of Surveillance | Surveillance Population | Cases with Clinical Data Collected |
---|---|---|
March– September 2020 | 14 states (CA, CO, CT, GA, IA, MD, MI, MN, NM, NY, OH, OR, TN, UT) | Sample of children and adults from all sites |
October 2020–September 2021 | 14 states (CA, CO, CT, GA, IA, MD, MI, MN, NM, NY, OH, OR, TN, UT) | Sample of children and adults from all sites |
October 2021–September 2022 | 14 states (CA, CO, CT, GA, IA, MD, MI, MN, NM, NY, OH, OR, TN, UT) | Sample of children and adults from all sites; incomplete data among Maryland cases for December 2021–June 2022 |
October 2022–September 2023 | 13 states (CA, CO, CT, GA, MD, MI, MN, NM, NY, OH, OR, TN, UT) | Sample of children and adults from all sites |
October 2023–Present | 13 states (CA, CO, CT, GA, MD, MI, MN, NM, NY, OH, OR, TN, UT) | Sample of children and adults from all sites |
COVID-NET Publications
- Ko JY, Pham H, Anglin O, et al. Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020—August 2022. Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093/cid/ciad266. Epub ahead of print.
- Shah MM, Patel K, Milucky J, et al. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020–April 2022. Influenza Other Respi Viruses. 2023 Mar 2;17(3):e13107. doi: 10.1111/irv.13107
- Woodruff RC, Garg S, George MG, et al. Acute Cardiac Events During COVID-19-Associated Hospitalizations. Journal of the American College of Cardiology. 2023 Feb 14;557–569.
- Agathis NT, Patel K, Milucky J, et al. Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19. Pediatrics. 2023 Feb;151 (2): e2022059037. 10.1542/peds.2022-059037
- O’Halloran A, Whitaker M, Patel K, et al. Developing a sampling methodology for timely reporting of population-based COVID-19-associated hospitalization surveillance in the United States, COVID-NET 2020–2021. Influenza Other Respi Viruses. 2023 Jan 10; 1-8.
Other Publications Using COVID-NET Data
- Wei SC, Freeman D, Himschoot A, et al. Who Gets Sick from COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods, 9/2020-11/202. J Infect Dis. 2023 Aug 24. Epub ahead of print. PMID: 37615368.
- Wallace M, Rosenblum HG, Moulia DL, et al. A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United StatesHy. Vaccine. 2023 Jul 30; Epub ahead of print. PMID: 37527956.
- Adams K, Tastad KJ, Huang S, et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season. MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1589–1596.
- Hamid S, Woodworth K, Pham H, et al. COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1442–1448.
- Havers FP, Pham H, Taylor CA, et al. COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022 | Critical Care Medicine | JAMA Internal Medicine | JAMA Network JAMA Intern Med. 2022 Oct 1;182(10):1071–1081.
- Havers FP, Patel K, Whitaker M, et al. Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71:1085–1091.
- Sekkarie A; Woodruff R, Whitaker M et al. Characteristics and treatment of hospitalized pregnant women with COVID-19. American Journal of Obstetrics & Gynecology MFM. Am J Obstet Gynecol MFM. 2022 Aug 12;4(6):100715.
- Singson JRC, Kirley PD, Pham H, et al. COVID-NET Surveillance Team, Reingold A, Chai SJ. Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 – COVID-NET, 10 States, March 2020-February 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 8;71(27):878-884.
- Delahoy MJ, Ujamaa D, Taylor CA, et al. Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021). Clin Infect Dis. 2022 May 20:ciac388.
- Shi DS, Whitaker M, Marks KJ, et al. Hospitalizations of Children Aged 5-11 with Laboratory-Confirmed COVID-19 ― COVID-NET, 14 States, March 2020-February 2022. MMWR Morb Mortal Wkly Rep. 2022 Apr 22;71(16):574-581
- Taylor CA, Whitaker M, Anglin O, et al. COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 25; 71(12):466-473.
- Marks KJ, Whitaker M, Agathis NT, et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429–436.
- Marks KJ, Whitaker M, Agathis NT, et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429–436.
- Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022 Jan 1;149(1):e2021053418.
Other Publications Using COVID-NET Data
- Steele MK, Couture A, Reed C, et al. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021. JAMA Netw Open. 2022 Jul 1;5(7):e2220385.
- Couture A, Iuliano D, Chang H, et al. Estimating COVID-19 Hospitalizations in the United States with Surveillance Data Using a Bayesian Hierarchical Model: A Modeling Study. JMIR Public Health Surveill. 2022 Jun 2;8(6):e34296.
- Taylor CA, Patel K, Pham H, et al. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513–1519.
- Acosta AM, Garg S, Pham H, et al. Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021. JAMA Netw Open.2021 Oct 1;4(10):e2130479.
- Wortham JM, Meador SA, Hadler JL, et al. Census tract socioeconomic indicators and COVID-19-associated hospitalization rates-COVID-NET surveillance areas in 14 states, March 1-April 30, 2020. PLoS One. 2021 Sep 24;16(9):e0257622.
- Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1255–1260.
- Havers, F. P., Pham, H., Taylor, C. A, et al. COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years – COVID-NET, 13 states, January 1 – July 24, 2021. 2021 Aug 29.
- Moline HL, Whitaker M, Deng L, et al. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093.
- Garg S, Patel K, Pham H, et al. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020: A Cross-Sectional Study. Ann Intern Med. 2021 Oct; 174(10):1409-1419.
- Havers FP, Whitaker M, Self JL, et al. Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):851–857.
- Ko JY, Danielson ML, Town M, et al. Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System.Clin Infect Dis. 2021 Jun 1;72 (11):e695-e703.
- Kim L, Garg S, O’Halloran A, et al. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).Clin Infect Dis. 2021 May 4;72(9): e26-e214.
- Owusu D, Kim L, O’Halloran A, et al. Characteristics of Adults aged 18-49 years without Underlying Medical Conditions Hospitalized with Laboratory Confirmed COVID-19 in the United States, COVID-NET – March – August 2020. Clin Infect Dis. 2021 Mar 1;72(5): e162-166.
Other Publications Using COVID-NET Data
- Cha S, Henry A, Montgomery MP, et al. Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19. J Infect Dis. 2021 Aug 2;224(3):425-430.
- Joo H, Miller GF, Sunshine G, et al. Decline in COVID-19 Hospitalization Growth Rates Associated with Statewide Mask Mandates — 10 States, March–October 2020. MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):212–216.
- Acosta AM, Mathis AL, Budnitz DS, et al. COVID-19 investigational treatments in use among hospitalized patients identified through the U.S. Coronavirus Disease 2019 -Associated Hospitalization Surveillance Network, March 1–June 30, 2020. Open Forum Infectious Disease. 2020 Nov 9;5(11): ofaa528.
- Kambhampati AK, O’Halloran AC, Whitaker M, et al. COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1576–1583.
- Delahoy MJ, Whitaker M, O’Halloran, et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347–1354.
- Kim L, Whitaker M, O’Halloran A, et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020.MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081–1088.
- Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464.
To receive email updates about COVID-19, enter your email address: